Assessing AI explanations by cancer doctors
Part of Cancer clinical trials.
This study asks lung cancer doctors at Penn Medicine to look at how an artificial intelligence tool explains its reasoning. The goal is to see if the explanations are clear and helpful for making treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a medical oncologist or hematologist/oncologist at Penn Medicine.
- You treat lung cancer patients.
- You have an email or physical address on file.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests new AI-created summaries of cancer imaging reports (like CT or MRI scans) that are written in plain language to help you better understand your results. Researchers want to see if these summaries help cancer patients and their doctors communicate more clearly about imaging findings.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This study tests whether an AI tool can help doctors read chest CT scans more accurately across the entire lung cancer care process. If you are a doctor who reads chest CT scans, you may be able to join and help improve cancer detection.
This trial tests whether artificial intelligence can help doctors plan better treatment for non-small cell lung cancer (NSCLC). A team of specialists will use AI tools alongside their usual approach to see if it improves care and safety.
This study tests how well an AI tool can predict lung cancer risk, based on your health information. It looks at how patients feel about this approach to screening, with the goal of making screening more personal and effective.
This study is testing an AI tool that helps explain prostate biopsy results in a way that is easier to understand. If you join, you'll review your pathology report with the help of this tool to see if it improves your understanding of your diagnosis.
Hear when a new Oncology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.